Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday after Bank of America raised their price target on the stock from $18.00 to $21.

A British woman thought she was embarking on a holiday of a lifetime to mark hers and husband's golden wedding anniversary.

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...

Israel says it has identified two of the dead bodies returned by Hamas on Thursday as Ariel and Kfir Bibas – but tests show ...

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Following in the bloody footsteps of Coralie Fargeat’s 'The Substance,' a new wave of female filmmakers is reinventing body ...

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...

Alright folks, Kylie Kelce is back at it with another revelation about her relationship with former Philadelphia Eagles ...

It can be easy to brush off awkward spaces in our homes as utterly useless and focus our design efforts elsewhere. Not Boston ...

BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 ...